Capricor Therapeutics, Inc. (CAPR)

NASDAQ: CAPR · Real-Time Price · USD

23.09

+1.20 (5.48%)

At close: Feb 2, 2026, 4:00 PM EST

23.10

+0.01 (0.04%)

After-hours: Feb 2, 2026, 6:22 PM EST

Capricor Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 2, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,194	627	151	95	71	70
Market Cap Growth	94.97%	316.72%	57.92%	34.76%	0.89%	1046.92%
Enterprise Value	1,085	544	124	49	30	35
Last Close Price	21.89	13.80	4.89	3.86	2.93	3.43
PS Ratio	89.31	28.18	5.98	37.37	288.92	226.06
PB Ratio	11.93	4.31	6.66	8.09	2.26	2.49
P/TBV Ratio	13.94	4.31	6.66	8.09	2.26	2.49
P/FCF Ratio	-	-	-	61.25	-	-
P/OCF Ratio	-	-	-	19.39	-	-
EV/Sales Ratio	97.49	24.43	4.94	19.10	122.30	113.31
EV/FCF Ratio	-	-	-	31.31	-	-
Debt / Equity Ratio	0.17	0.01	0.10	0.22	0.09	0.01
Debt / FCF Ratio	-	-	-	1.64	-	-
Asset Turnover	0.10	0.19	0.46	0.06	0.01	0.01
Quick Ratio	3.50	7.70	1.59	1.78	8.54	11.01
Current Ratio	3.59	7.77	1.63	1.82	8.82	11.33
Return on Equity (ROE)	-107.79%	-48.16%	-129.63%	-134.49%	-67.23%	-77.95%
Return on Assets (ROA)	-49.39%	-23.21%	-27.66%	-40.60%	-34.46%	-37.42%
Return on Capital Employed (ROCE)	-88.20%	-28.50%	-87.70%	-112.00%	-56.30%	-43.30%
Earnings Yield	-7.01%	-6.45%	-14.80%	-30.43%	-28.30%	-19.47%
FCF Yield	-5.85%	-6.62%	-18.36%	1.63%	-25.45%	-15.12%
Buyback Yield / Dilution	-43.02%	-31.52%	-9.06%	-6.34%	-48.28%	-319.55%

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q